Trikafta’s sticker price is more than $300,000 a year. Insurance typically covers most of that cost—minus what can be significant co-pays and deductibles—and Vertex offers co-pay assistance.

Trikafta, he told me, made a clear difference for this baby girl. Cystic fibrosis is caused by an imbalance of salt and water in the body, and this affects developing organs even before birth.

The cystic fibrosis drug Trikafta helps roughly 90 percent of people who have the deadly genetic disease. The drug enables patients to live a healthy life, start families, and think of a future.

Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.

Trikafta has transformed my life in ways I never thought possible. But with that came a sharp awareness of those still waiting for a treatment that works for them. That’s why I’m deeply committed to ...

Zacks Investment Research. Image Source: Zacks Investment Research. VRTX Secures FDA’s Expanded Nod for Trikafta. In a separate press release, Vertex announced that the FDA has expanded Trikafta ...

Trikafta is taken by only a few hundred Coloradans, and so its list price of more than $300,000 per year seems exceptionally high. This simple fact skews the per-patient metric, ...

The approval was based on data from a 24-week open-label, two-part phase 3 study (ClinicalTrials.gov Identifier: NCT04537793) that evaluated the efficacy and safety of Trikafta in 75 children 2 to ...

TRIKAFTA ® was previously approved by Health Canada for use in people with CF aged 2 years and older with at least one F508del mutation and is now approved for 152 additional mutations.

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.